References
1. Lung B., Delgado V., Rosenhek R. et al.; EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019; 140: 1156–69.
2. Zoghbi W.A., Adams D., Bonow R.O., et al. Recommendations for noninvasive evaluation of native valvular regurgitation. A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017; 30 (4): 303–71. DOI: https://doi.org/10.1016/j.echo.2017.01.007
3. Erbel R., Aboyans V., Boileau C., et al.; ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35: 2873–926.
4. Goldstein S.A., Evangelista A., Abbara S., et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2015; 28: 119–82.
5. Vahanian A., Beyersdorf F., Praz F., et al.; ESC/EACTS Scientific Document Group, ESC National Cardiac Societies. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022; 43 (7): 561–632. DOI: https://doi.org/10.1093/eurheartj/ehab395
6. Evangelista A., Sitges M., Jondeau G. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. Eur Heart J Cardiovasc Imaging. 2023: 24 (5): 1–21. DOI: https://doi.org/10.1093/ehjci/jead024
7. Isselbacher E.M., Preventza O., Hamilton Black J. 3rd, et al. 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 146 (24): 334–482. DOI: https://doi.org/10.1161/CIR.0000000000001106
8. Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., et al.; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129 (23): 2440–92. DOI: https://doi.org/10.1161/CIR.0000000000000029
9. Lancellotti P., Pibarot Ph., Chambers J., et al.; The Scientific Document Committee of the European Association of Cardiovascular Imaging. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging. 2022; 23 (5): e171–232. DOI: https://doi.org/10.1093/ehjci/jeab253
10. Lancellotti P., Pellikka P.A., Budts W., et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2016; 17 (11): 1191–229. DOI: https://doi.org/10.1093/ehjci/jew190
11. Kaneko T., Ejiofor J.I., Neely R.C., et al. Aortic regurgitation with markedly reduced left ventricular function is not a contraindication for aortic valve replacement. Ann Thorac Surg. 2016; 102: 41–7.
12. Yoon S.H., Schmidt T., Bleiziffer S., et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol. 2017; 70: 2752–63.
13. Desai M.Y., Kalahasti V., Hutt Centeno E., et al. Adult patients with Marfan syndrome and ascending aortic surgery. J Am Coll Cardiol. 2019; 73: 733–4.
14. Baumgartner H., De Backer J., Babu-Narayan S.V., et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42: 563–645.
15. Alashi A., Khullar T., Mentias A., et al. Long-term outcomes after aortic valve surgery in patients with asymptomatic chronic aortic regurgitation and preserved LVEF: impact of baseline and follow-up global longitudinal strain. JACC Cardiovasc Imaging. 2020; 13: 12–21.
16. Elbatarny M., Tam D.Y., Edelman J.J., et al.; Canadian Thoracic Aortic Collaborative Investigators. Valve-sparing root replacement versus composite valve grafting in aortic root dilation: a meta-analysis. Ann Thorac Surg. 2020; 110: 296–306.
17. Leontyev S., Schamberger L., Davierwala P.M., et al. Early and late results after David vs Bentall procedure: a propensity matched analysis. Ann Thorac Surg. 2020; 110: 120–6.